The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
Targeting DNA methylation for epigenetic therapy
Open accessAbstract
DNA methylation patterns are established during embryonic development and faithfully copied through somatic cell divisions. Based on our understanding of DNA methylation and other interrelated epigenetic modifications, a comprehensive view of the epigenetic landscape and cancer epigenome is evolving. The cancer methylome is highly disrupted, making DNA methylation an excellent target for anti-cancer therapies. During the last few decades, an increasing number of drugs targeting DNA methylation have been developed in an effort to increase efficacy, stability and to decrease toxicity. The earliest and the most successful epigenetic drug to date, 5-Azacytidine, is currently recommended as the first-line treatment for high risk myelodysplastic syndromes (MDS) patients. Encouraging results from clinical trials have prompted further efforts to elucidate epigenetic alterations in cancer and subsequently develop new epigenetic therapies. This review delineates the latest cancer epigenetic models, recent discovery of hypomethylation agents and their application in the clinic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Ghoshal, K., Datta, J., Majumder, S., Bai, S., Kutay, H., Motiwala, T., & Jacob, S. T. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.11.4727-4741.2005 · Cited by 431
RetractedDatta, J., Ghoshal, K., Denny, W. A., Gamage, S. A., Brooke, D. G., Phiasivongsa, P., Redkar, S., & Jacob, S. T. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3669 · Cited by 270
RetractedChromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
High-Resolution Profiling of Histone Methylations in the Human Genome
Barski, A., Cuddapah, S., Cui, K., Roh, T.-Y., Schones, D. E., Wang, Z., Wei, G., Chepelev, I., & Zhao, K. (2007) · Cell · doi:10.1016/j.cell.2007.05.009 · Cited by 6,845
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143
Human DNA methylomes at base resolution show widespread epigenomic differences
Lister, R., Pelizzola, M., Dowen, R. H., Hawkins, R. D., Hon, G., Tonti-Filippini, J., Nery, J. R., Lee, L., Ye, Z., Ngo, Q.-M., et al. (2009) · Nature · doi:10.1038/nature08514 · Cited by 4,673
Jones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515
Self-citationGenome-wide maps of chromatin state in pluripotent and lineage-committed cells
Mikkelsen, T. S., Ku, M., Jaffe, D. B., Issac, B., Lieberman, E., Giannoukos, G., Alvarez, P., Brockman, W., Kim, T.-K., Koche, R. P., et al. (2007) · Nature · doi:10.1038/nature06008 · Cited by 4,129
The Role of Chromatin during Transcription
Li, B., Carey, M., & Workman, J. L. (2007) · Cell · doi:10.1016/j.cell.2007.01.015 · Cited by 3,533
Nan, X., Ng, H.-H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N., & Bird, A. (1998) · Nature · doi:10.1038/30764 · Cited by 3,440
Heintzman, N. D., Stuart, R. K., Hon, G., Fu, Y., Ching, C. W., Hawkins, R. D., Barrera, L. O., Van Calcar, S., Qu, C., Ching, K. A., et al. (2007) · Nature Genetics · doi:10.1038/ng1966 · Cited by 3,398
DNA methylation landscapes: Provocative insights from epigenomics
Suzuki, M. M., & Bird, A. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2341 · Cited by 3,039
The complex language of chromatin regulation during transcription
Berger, S. L. (2007) · Nature · doi:10.1038/nature05915 · Cited by 2,768
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription
Jones, P. L., Veenstra, G. J. C., Wade, P. A., Vermaak, D., Kass, S. U., Landsberger, N., Strouboulis, J., & Wolffe, A. P. (1998) · Nature Genetics · doi:10.1038/561 · Cited by 2,730
Self-citationThe polycomb group protein EZH2 is involved in progression of prostate cancer
Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717
Fenaux, P., Mufti, G. J., Hellstrom-Lindberg, E., Santini, V., Finelli, C., Giagounidis, A., Schoch, R., Gattermann, N., Sanz, G., List, A., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70003-8 · Cited by 2,663 · cited 2×
“[102, 104] MDS Fenaux (2009) 358 17% CR, 12% PR, 42% SD Improved OS compared to CCR in high risk MDS patients (AZA-001).”
BackgroundIdentification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
Noushmehr, H., Weisenberger, D. J., Diefes, K., Phillips, H. S., Pujara, K., Berman, B. P., Pan, F., Pelloski, C. E., Sulman, E. P., Bhat, K. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.017 · Cited by 2,337
Combinatorial patterns of histone acetylations and methylations in the human genome
Wang, Z., Zang, C., Rosenfeld, J. A., Schones, D. E., Barski, A., Cuddapah, S., Cui, K., Roh, T.-Y., Peng, W., Zhang, M. Q., et al. (2008) · Nature Genetics · doi:10.1038/ng.154 · Cited by 2,331
Linking DNA methylation and histone modification: patterns and paradigms
Cedar, H., & Bergman, Y. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2540 · Cited by 2,267
The Polycomb group protein EZH2 directly controls DNA methylation
Viré, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J.-M., et al. (2006) · Nature · doi:10.1038/nature04431 · Cited by 2,204
Irizarry, R. A., Ladd-Acosta, C., Wen, B., Wu, Z., Montano, C., Onyango, P., Cui, H., Gabo, K., Rongione, M., Webster, M., et al. (2009) · Nature Genetics · doi:10.1038/ng.298 · Cited by 2,177
Cancer epigenomics: DNA methylomes and histone-modification maps
Esteller, M. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2005 · Cited by 2,146
A Chromatin Landmark and Transcription Initiation at Most Promoters in Human Cells
Guenther, M. G., Levine, S. S., Boyer, L. A., Jaenisch, R., & Young, R. A. (2007) · Cell · doi:10.1016/j.cell.2007.05.042 · Cited by 1,944
Cellular differentiation, cytidine analogs and DNA methylation
Jones, P. A., & Taylor, S. M. (1980) · Cell · doi:10.1016/0092-8674(80)90237-8 · Cited by 1,831
Self-citationSilverman, L. R., Demakos, E. P., Peterson, B. L., Kornblith, A. B., Holland, J. C., Odchimar-Reissig, R., Stone, R. M., Nelson, D., Powell, B. L., DeCastro, C. M., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.04.117 · Cited by 1,825
Genome-Wide Evolutionary Analysis of Eukaryotic DNA Methylation
Zemach, A., McDaniel, I. E., Silva, P., & Zilberman, D. (2010) · Science · doi:10.1126/science.1186366 · Cited by 1,793
DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA
Ooi, S. K. T., Qiu, C., Bernstein, E., Li, K., Jia, D., Yang, Z., Erdjument-Bromage, H., Tempst, P., Lin, S.-P., Allis, C. D., et al. (2007) · Nature · doi:10.1038/nature05987 · Cited by 1,567
Kantarjian, H., Issa, J. J., Rosenfeld, C. S., Bennett, J. M., Albitar, M., DiPersio, J., Klimek, V., Slack, J., de Castro, C., Ravandi, F., et al. (2006) · Cancer · doi:10.1002/cncr.21792 · Cited by 1,530
Comprehensive analysis of CpG islands in human chromosomes 21 and 22
Takai, D., & Jones, P. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052410099 · Cited by 1,514
Self-citationUHRF1 Plays a Role in Maintaining DNA Methylation in Mammalian Cells
Bostick, M., Kim, J. K., Estève, P.-O., Clark, A., Pradhan, S., & Jacobsen, S. E. (2007) · Science · doi:10.1126/science.1147939 · Cited by 1,455
Dnmt3L and the Establishment of Maternal Genomic Imprints
Bourc'his, D., Xu, G.-L., Lin, C.-S., Bollman, B., & Bestor, T. H. (2001) · Science · doi:10.1126/science.1065848 · Cited by 1,439
Genome Regulation by Polycomb and Trithorax Proteins
Schuettengruber, B., Chourrout, D., Vervoort, M., Leblanc, B., & Cavalli, G. (2007) · Cell · doi:10.1016/j.cell.2007.02.009 · Cited by 1,430
Chromosomal Instability and Tumors Promoted by DNA Hypomethylation
Eden, A., Gaudet, F., Waghmare, A., & Jaenisch, R. (2003) · Science · doi:10.1126/science.1083557 · Cited by 1,399
Saito, Y., Liang, G., Egger, G., Friedman, J. M., Chuang, J. C., Coetzee, G. A., & Jones, P. A. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.020 · Cited by 1,335
Self-citationEpigenetic therapy of cancer: past, present and future
Yoo, C. B., & Jones, P. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1930 · Cited by 1,289
Self-citationSchlesinger, Y., Straussman, R., Keshet, I., Farkash, S., Hecht, M., Zimmerman, J., Eden, E., Yakhini, Z., Ben-Shushan, E., Reubinoff, B. E., et al. (2007) · Nature Genetics · doi:10.1038/ng1950 · Cited by 1,226
Ohm, J. E., McGarvey, K. M., Yu, X., Cheng, L., Schuebel, K. E., Cope, L., Mohammad, H. P., Chen, W., Daniel, V. C., Yu, W., et al. (2007) · Nature Genetics · doi:10.1038/ng1972 · Cited by 1,130
Multiple new phenotypes induced in and 3T3 cells treated with 5-azacytidine
Taylor, S. M., & Jones, P. A. (1979) · Cell · doi:10.1016/0092-8674(79)90317-9 · Cited by 1,100
Self-citationA microRNA DNA methylation signature for human cancer metastasis
Lujambio, A., Calin, G. A., Villanueva, A., Ropero, S., Sánchez-Céspedes, M., Blanco, D., Montuenga, L. M., Rossi, S., Nicoloso, M. S., Faller, W. J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803055105 · Cited by 1,078
Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer
Varambally, S., Cao, Q., Mani, R.-S., Shankar, S., Wang, X., Ateeq, B., Laxman, B., Cao, X., Jing, X., Ramnarayanan, K., et al. (2008) · Science · doi:10.1126/science.1165395 · Cited by 1,052
Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine
Stresemann, C., & Lyko, F. (2008) · International Journal of Cancer · doi:10.1002/ijc.23607 · Cited by 949
Tan, J., Yang, X., Zhuang, L., Jiang, X., Chen, W., Lee, P. L., Karuturi, R. K. M., Tan, P. B. O., Liu, E. T., & Yu, Q. (2007) · Genes & Development · doi:10.1101/gad.1524107 · Cited by 895
Self-citationStructure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation
Jia, D., Jurkowska, R. Z., Zhang, X., Jeltsch, A., & Cheng, X. (2007) · Nature · doi:10.1038/nature06146 · Cited by 846
Garzon, R., Liu, S., Fabbri, M., Liu, Z., Heaphy, C. E. A., Callegari, E., Schwind, S., Pang, J., Yu, J., Muthusamy, N., et al. (2009) · Blood · doi:10.1182/blood-2008-07-170589 · Cited by 781
Jin, C., Zang, C., Wei, G., Cui, K., Peng, W., Zhao, K., & Felsenfeld, G. (2009) · Nature Genetics · doi:10.1038/ng.409 · Cited by 775
Rethinking how DNA methylation patterns are maintained
Jones, P. A., & Liang, G. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2651 · Cited by 765
Self-citationKantarjian, H., Oki, Y., Garcia-Manero, G., Huang, X., O'Brien, S., Cortes, J., Faderl, S., Bueso-Ramos, C., Ravandi, F., Estrov, Z., et al. (2007) · Blood · doi:10.1182/blood-2006-05-021162 · Cited by 685
Chromatin structure analyses identify miRNA promoters
Ozsolak, F., Poling, L. L., Wang, Z., Liu, H., Liu, X. S., Roeder, R. G., Zhang, X., Song, J. S., & Fisher, D. E. (2008) · Genes & Development · doi:10.1101/gad.1706508 · Cited by 678
Kondo, Y., Shen, L., Cheng, A. S., Ahmed, S., Boumber, Y., Charo, C., Yamochi, T., Urano, T., Furukawa, K., Kwabi-Addo, B., et al. (2008) · Nature Genetics · doi:10.1038/ng.159 · Cited by 620
Toyota, M., Suzuki, H., Sasaki, Y., Maruyama, R., Imai, K., Shinomura, Y., & Tokino, T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0325 · Cited by 600
Histone H2A.Z and DNA methylation are mutually antagonistic chromatin marks
Zilberman, D., Coleman-Derr, D., Ballinger, T., & Henikoff, S. (2008) · Nature · doi:10.1038/nature07324 · Cited by 593
Silverman, L. R., McKenzie, D. R., Peterson, B. L., Holland, J. F., Backstrom, J. T., Beach, C. L., & Larson, R. A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.4346 · Cited by 552
Lübbert, M., Suciu, S., Baila, L., Rüter, B. H., Platzbecker, U., Giagounidis, A., Selleslag, D., Labar, B., Germing, U., Salih, H. R., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.9245 · Cited by 552
Recognition of hemi-methylated DNA by the SRA protein UHRF1 by a base-flipping mechanism
Arita, K., Ariyoshi, M., Tochio, H., Nakamura, Y., & Shirakawa, M. (2008) · Nature · doi:10.1038/nature07249 · Cited by 515
Upregulation and Nuclear Recruitment of HDAC1 in Hormone Refractory Prostate Cancer
Halkidou, K., Gaughan, L., Cook, S., Leung, H. Y., Neal, D. E., & Robson, C. N. (2004) · The Prostate · doi:10.1002/pros.20022 · Cited by 509
Liang, G., Lin, J. C. Y., Wei, V., Yoo, C., Cheng, J. C., Nguyen, C. T., Weisenberger, D. J., Egger, G., Takai, D., Gonzales, F. A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401866101 · Cited by 484
Self-citationNucleosome dynamics define transcriptional enhancers
He, H. H., Meyer, C. A., Shin, H., Bailey, S. T., Wei, G., Wang, Q., Zhang, Y., Xu, K., Ni, M., Lupien, M., et al. (2010) · Nature Genetics · doi:10.1038/ng.545 · Cited by 475
Lim, S., Janzer, A., Becker, A., Zimmer, A., Schüle, R., Buettner, R., & Kirfel, J. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp324 · Cited by 470
Garcia-Manero, G., Kantarjian, H. M., Sanchez-Gonzalez, B., Yang, H., Rosner, G., Verstovsek, S., Rytting, M., Wierda, W. G., Ravandi, F., Koller, C., et al. (2006) · Blood · doi:10.1182/blood-2006-03-009142 · Cited by 467
Blum, W., Garzon, R., Klisovic, R. B., Schwind, S., Walker, A., Geyer, S., Liu, S., Havelange, V., Becker, H., Schaaf, L., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002650107 · Cited by 450
Issa, J.-P. J., & Kantarjian, H. M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2783 · Cited by 446
Schulte, J. H., Lim, S., Schramm, A., Friedrichs, N., Koster, J., Versteeg, R., Ora, I., Pajtler, K., Klein-Hitpass, L., Kuhfittig-Kulle, S., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1735 · Cited by 445
G9a/GLP complexes independently mediate H3K9 and DNA methylation to silence transcription
Tachibana, M., Matsumura, Y., Fukuda, M., Kimura, H., & Shinkai, Y. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.192 · Cited by 429
Kornblith, A. B., Herndon, J. E., Silverman, L. R., Demakos, E. P., Odchimar-Reissig, R., Holland, J. F., Powell, B. L., DeCastro, C., Ellerton, J., Larson, R. A., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.04.044 · Cited by 419
Epigenetic Control of Mouse Oct-4 Gene Expression in Embryonic Stem Cells and Trophoblast Stem Cells
Hattori, N., Nishino, K., Ko, Y.-G., Hattori, N., Ohgane, J., Tanaka, S., & Shiota, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309002200 · Cited by 397
Soriano, A. O., Yang, H., Faderl, S., Estrov, Z., Giles, F., Ravandi, F., Cortes, J., Wierda, W. G., Ouzounian, S., Quezada, A., et al. (2007) · Blood · doi:10.1182/blood-2007-03-078576 · Cited by 390
Functional Diversity of DNA Methyltransferase Inhibitors in Human Cancer Cell Lines
Stresemann, C., Brueckner, B., Musch, T., Stopper, H., & Lyko, F. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2821 · Cited by 385
Nguyen, C. T., Weisenberger, D. J., Velicescu, M., Gonzales, F. A., Lin, J., Liang, G., & Jones, P. A. (2002) · PubMed · Cited by 383
Self-citationFriedman, J. M., Liang, G., Liu, C.-C., Wolff, E. M., Tsai, Y. C., Ye, W., Zhou, X., & Jones, P. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3114 · Cited by 382
Self-citationGal-Yam, E. N., Egger, G., Iniguez, L., Holster, H., Einarsson, S., Zhang, X., Lin, J. C., Liang, G., Jones, P. A., & Tanay, A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806437105 · Cited by 380
Self-citationGenome-wide approaches to studying chromatin modifications
Schones, D. E., & Zhao, K. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2270 · Cited by 369
A Comparison of Azacitidine and Decitabine Activities in Acute Myeloid Leukemia Cell Lines
Hollenbach, P. W., Nguyen, A. N., Brady, H., Williams, M., Ning, Y., Richard, N., Krushel, L., Aukerman, S. L., Heise, C., & MacBeth, K. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009001 · Cited by 362
Increased expression of histone deacetylase 2 is found in human gastric cancer
SONG, J., NOH, J. H., LEE, J. H., EUN, J. W., AHN, Y. M., KIM, S. Y., LEE, S. H., PARK, W. S., YOO, N. J., LEE, J. Y., et al. (2005) · APMIS · doi:10.1111/j.1600-0463.2005.apm_04.x · Cited by 346
Creyghton, M. P., Markoulaki, S., Levine, S. S., Hanna, J., Lodato, M. A., Sha, K., Young, R. A., Jaenisch, R., & Boyer, L. A. (2008) · Cell · doi:10.1016/j.cell.2008.09.056 · Cited by 340
MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation
Figueroa, M. E., Skrabanek, L., Li, Y., Jiemjit, A., Fandy, T. E., Paietta, E., Fernandez, H., Tallman, M. S., Greally, J. M., Carraway, H., et al. (2009) · Blood · doi:10.1182/blood-2009-01-200519 · Cited by 325
Steensma, D. P., Baer, M. R., Slack, J. L., Buckstein, R., Godley, L. A., Garcia-Manero, G., Albitar, M., Larsen, J. S., Arora, S., Cullen, M. T., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.6550 · Cited by 319
High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer
Rauch, T. A., Zhong, X., Wu, X., Wang, M., Kernstine, K. H., Wang, Z., Riggs, A. D., & Pfeifer, G. P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710735105 · Cited by 318
Phase I Study of Decitabine Alone or in Combination With Valproic Acid in Acute Myeloid Leukemia
Blum, W., Klisovic, R. B., Hackanson, B., Liu, Z., Liu, S., Devine, H., Vukosavljevic, T., Huynh, L., Lozanski, G., Kefauver, C., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.4169 · Cited by 315
Flotho, C., Claus, R., Batz, C., Schneider, M., Sandrock, I., Ihde, S., Plass, C., Niemeyer, C. M., & Lübbert, M. (2009) · Leukemia · doi:10.1038/leu.2008.397 · Cited by 315
Fandy, T. E., Herman, J. G., Kerns, P., Jiemjit, A., Sugar, E. A., Choi, S.-H., Yang, A. S., Aucott, T., Dauses, T., Odchimar-Reissig, R., et al. (2009) · Blood · doi:10.1182/blood-2009-02-203547 · Cited by 282
Lyons, R. M., Cosgriff, T. M., Modi, S. S., Gersh, R. H., Hainsworth, J. D., Cohn, A. L., McIntyre, H. J., Fernando, I. J., Backstrom, J. T., & Beach, C. L. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.1058 · Cited by 274
Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis
Wu, H., Chen, Y., Liang, J., Shi, B., Wu, G., Zhang, Y., Wang, D., Li, R., Yi, X., Zhang, H., et al. (2005) · Nature · doi:10.1038/nature04225 · Cited by 273
An evaluation of new criteria for CpG islands in the human genome as gene markers
Wang, Y., & Leung, F. C. C. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth059 · Cited by 267
Zlatanova, J., & Thakar, A. (2008) · Structure · doi:10.1016/j.str.2007.12.008 · Cited by 266
DNA Methylation Changes after 5-Aza-2′-Deoxycytidine Therapy in Patients with Leukemia
Yang, A. S., Doshi, K. D., Choi, S.-W., Mason, J. B., Mannari, R. K., Gharybian, V., Luna, R., Rashid, A., Shen, L., Estecio, M. R. H., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2385 · Cited by 266
Cytotoxicity and mode of action of 5-azacytidine on L1210 leukemia.
Li, L. H., Olin, E. J., Buskirk, H. H., & REINEKE, L. M. (1970) · PubMed · Cited by 263
DNA methylation in ES cells requires the lysine methyltransferase G9a but not its catalytic activity
Dong, K. B., Maksakova, I. A., Mohn, F., Leung, D., Appanah, R., Lee, S., Yang, H. W., Lam, L. L., Mager, D. L., Schübeler, D., et al. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.193 · Cited by 242
Mechanisms of resistance to 5-aza-2′-deoxycytidine in human cancer cell lines
Qin, T., Jelinek, J., Si, J., Shu, J., & Issa, J.-P. J. (2009) · Blood · doi:10.1182/blood-2008-02-140038 · Cited by 237
Appleton, K., Mackay, H. J., Judson, I., Plumb, J. A., McCormick, C., Strathdee, G., Lee, C., Barrett, S., Reade, S., Jadayel, D., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.8688 · Cited by 228
Schrump, D. S., Fischette, M. R., Nguyen, D. M., Zhao, M., Li, X., Kunst, T. F., Hancox, A., Hong, J. A., Chen, G. A., Pishchik, V., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0669 · Cited by 227
DNA hypomethylation in the origin and pathogenesis of human diseases
Pogribny, I. P., & Beland, F. A. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0015-5 · Cited by 220
Chuang, J. C., Yoo, C. B., Kwan, J. M., Li, T. W. H., Liang, G., Yang, A. S., & Jones, P. A. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0172 · Cited by 210
Self-citationRole of Nucleosomal Occupancy in the Epigenetic Silencing of the MLH1 CpG Island
Lin, J. C., Jeong, S., Liang, G., Takai, D., Fatemi, M., Tsai, Y. C., Egger, G., Gal-Yam, E. N., & Jones, P. A. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.10.014 · Cited by 206
Self-citationSelective Anchoring of DNA Methyltransferases 3A and 3B to Nucleosomes Containing Methylated DNA
Jeong, S., Liang, G., Sharma, S., Lin, J. C., Choi, S. H., Han, H., Yoo, C. B., Egger, G., Yang, A. S., & Jones, P. A. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00484-09 · Cited by 192
Self-citationZebularine: a new drug for epigenetic therapy
Yoo, C. B., Cheng, J. C., & Jones, P. A. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320910 · Cited by 191
Self-citationDNA methyltransferase levels in tumorigenic and nontumorigenic cells in culture.
Kautiainen, T. L., & Jones, P. A. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35981-1 · Cited by 183
Self-citationBraiteh, F., Soriano, A. O., Garcia-Manero, G., Hong, D., Johnson, M. M., Silva, L. D. P., Yang, H., Alexander, S., Wolff, J., & Kurzrock, R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1247 · Cited by 164
Chuang, J. C., Warner, S. L., Vollmer, D. L., Vankayalapati, H., Redkar, S., Bearss, D. J., Qiu, X., Yoo, C. B., & Jones, P. A. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1048 · Cited by 164
Self-citationHistone H2A.Z is essential for estrogen receptor signalingPreprint
Gévry, N. Y., Hardy, S., Jacques, P., Laflamme, L., Svotelis, A., Robert, F., & Gaudreau, L. R. (2009) · Genes & Development · doi:10.1101/gad.1787109 · Cited by 162
DNA Methylation Dictates Histone H3K4 Methylation
Okitsu, C. Y., & Hsieh, C. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02291-06 · Cited by 161
Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells
Billam, M., Sobolewski, M. D., & Davidson, N. E. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0420-3 · Cited by 158
Stewart, D. J., Issa, J. J., Kurzrock, R., Nunez, M. I., Jelı́nek, J., Hong, D. S., Oki, Y., Guo, Z., Gupta, S. K., & Wistuba, I. I. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2196 · Cited by 139
Oki, Y., Kantarjian, H. M., Gharibyan, V., Jones, D. M., O'Brien, S. M., Verstovšek, S., Cortes, J. E., Morris, G. M., Garcia‐Manero, G., & Issa, J. J. (2007) · Cancer · doi:10.1002/cncr.22470 · Cited by 137
Gollob, J., Sciambi, C. J., Peterson, B. L., Richmond, T. M., Thoreson, M., Moran, K., Dressman, H. K., Jelínek, J., & Issa, J. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0883 · Cited by 133
5-azacytidine treatment reorganizes genomic histone modification patterns
Komashko, V., & Farnham, P. (2010) · Epigenetics · doi:10.4161/epi.5.3.11409 · Cited by 121
Reconciling the positive and negative roles of histone H2A.Z in gene transcription
Marques, M., Laflamme, L., Gervais, A. L., & Gaudreau, L. R. (2010) · Epigenetics · doi:10.4161/epi.5.4.11520 · Cited by 118
Molecular Modeling and Molecular Dynamics Studies of Hydralazine with Human DNA Methyltransferase 1
Singh, N. P., Dueñas‐González, A., Lyko, F., & Medina‐Franco, J. L. (2009) · ChemMedChem · doi:10.1002/cmdc.200900017 · Cited by 115
Plummer, R., Vidal, L., Griffin, M., Lesley, M., Bono, J. S. D., Coulthard, S. A., Sludden, J., Siu, L. L., Chen, E. X., Oza, A. M., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2859 · Cited by 112
5-Azacytidine–Induced Methyltransferase-DNA Adducts Block DNA Replication In vivo
Kuo, H.-C., Griffith, J. D., & Kreuzer, K. N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1038 · Cited by 111
Identification of Novel High-Frequency DNA Methylation Changes in Breast Cancer
Ordway, J. M., Budiman, M. A., Korshunova, Y. O., Maloney, R. K., Bedell, J. A., Citek, R. W., Bacher, B., Peterson, S., Rohlfing, T., Hall, J. A., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001314 · Cited by 111
Sekeres, M. A., List, A. F., Cuthbertson, D. D., PAQUETTE, R. L., Ganetsky, R., Latham, D., Paulic, K., Afable, M. G., Saba, H. I., Loughran, T. P., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.0745 · Cited by 109
Azacitidine for the treatment of lower risk myelodysplastic syndromes
Musto, P., Maurillo, L., Spagnoli, A., Gozzini, A., Rivellini, F., Lunghi, M., Villani, O., Spiriti, M. A. A., Venditti, A., & Santini, V. (2010) · Cancer · doi:10.1002/cncr.24894 · Cited by 107
Suzuki, T., Tanaka, R., Hamada, S., Nakagawa, H., & Miyata, N. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.12.016 · Cited by 103
Voso, M. T., Santini, V., Finelli, C., Musto, P., Pogliani, E., Angelucci, E., Fioritoni, G., Alimena, G., Maurillo, L., Cortelezzi, A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0494 · Cited by 102
Yoo, C. B., Chuang, J. C., Byun, H., Egger, G., Yang, A. S., Dubeau, L., Long, T. I., Laird, P. W., Márquez, V. E., & Jones, P. A. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-07-0008 · Cited by 102
Self-citationSegura-Pacheco, B. A., Pérez‐Cárdenas, E., Taja‐Chayeb, L., Chávez-Blanco, A. D., Vázquez, A. L. R., Benı́tez-Bribiesca, L., & Dueñas‐González, A. (2006) · Journal of Translational Medicine · doi:10.1186/1479-5876-4-32 · Cited by 93
Klisovic, R. B., Stock, W., Cataland, S. R., Klisovic, M. I., Liu, S., Blum, W. G., Green, M., Odenike, O. M., Godley, L. A., Burgt, J. A. V., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1320 · Cited by 87
Lin, J., Gilbert, J., Rudek, M. A., Zwiebel, J. A., Gore, S. D., Jiemjit, A., Zhao, M., Baker, S. D., Ambinder, R. F., Herman, J. G., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0567 · Cited by 83
Inhibition of DNA Methylation by Antisense Oligonucleotide MG98 as Cancer Therapy
Amato, R. J. (2007) · Clinical Genitourinary Cancer · doi:10.3816/cgc.2007.n.029 · Cited by 79
Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndrome
Silva, L. D. P., Lima, M. J. G. D., Kantarjian, H. M., Faderl, S., Kebriaei, P., Giralt, S., Davisson, J., Garcia‐Manero, G., Champlin, R. E., Issa, J. J., et al. (2009) · Bone Marrow Transplantation · doi:10.1038/bmt.2008.400 · Cited by 77
Fenaux, P., Gattermann, N., Seymour, J. F., Hellström‐Lindberg, E., Mufti, G. J., Dührsen, U., Gore, S. D., Ramos, F., Beyne‐Rauzy, O., List, A. F., et al. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08082.x · Cited by 76
Dynamic Histone Variant Exchange Accompanies Gene Induction in T Cells
Sutcliffe, E. L., Parish, I. A., He, Y., Juelich, T., Tierney, M. L., Rangasamy, D., Milburn, P. J., Parish, C. R., Tremethick, D. J., & Rao, S. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01590-08 · Cited by 76
Rius, M., Stresemann, C., Keller, D. B., Brom, M., Schirrmacher, E., KEPPLER, D. O. R., & Lyko, F. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0743 · Cited by 73
Beumer, J. H., Parise, R. A., Newman, E. M., Doroshow, J. H., Synold, T. W., Lenz, H., & Egorin, M. J. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0603-8 · Cited by 72
Raza, A., Mehdi, M., Mumtaz, M. A., Ali, F., Lascher, S., & Galili, N. (2008) · Cancer · doi:10.1002/cncr.23789 · Cited by 69
Beumer, J. H., Eiseman, J. L., Parise, R. A., Joseph, E., Holleran, J. L., Covey, J. M., & Egorin, M. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1250 · Cited by 62
Lemaire, M., Momparler, L. F., Raynal, N. J. ‐., Bernstein, M. L., & Momparler, R. L. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0750-6 · Cited by 59
Byun, H., Choi, S. H., Laird, P. W., Trinh, B., Siddiqui, M. A., Márquez, V. E., & Yang, A. S. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.069 · Cited by 54
Polyamine analogues targeting epigenetic gene regulation
Huang, Y., Marton, L. J., Woster, P. M., & Casero, R. A. (2009) · Essays in Biochemistry · doi:10.1042/bse0460007 · Cited by 54
Prolonged responses in patients with MDS and CMML treated with azacitidine and etanercept
Scott, B. L., Ramakrishnan, A., Storer, B. E., Becker, P. S., Petersdorf, S., Estey, E. H., & Deeg, H. J. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.08061.x · Cited by 42
Borthakur, G. M., Huang, X., Kantarjian, H. M., Faderl, S., Ravandi, F., Ferrajoli, A., Torma, R., Morris, G., Berry, D. A., & Issa, J. J. (2009) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190903318329 · Cited by 35
Decitabine treatment of patients with higher-risk myelodysplastic syndromes
Steensma, D. P. (2009) · Leukemia Research · doi:10.1016/s0145-2126(09)70228-0 · Cited by 22
Azacitidine in lower-risk myelodysplastic syndromes
Santini, V. (2009) · Leukemia Research · doi:10.1016/s0145-2126(09)70230-9 · Cited by 12
Kratzke, R. A., Wang, X., Wong, L., Kratzke, M. G., Green, M. R., Vokes, E. E., Vogelzang, N. J., Kindler, H. L., & Kern, J. A. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318168da0a · Cited by 11
Cited by
Cancer epigenetics reaches mainstream oncology
Rodríguez-Paredes, M., & Esteller, M. (2011) · Nature Medicine · doi:10.1038/nm.2305 · Cited by 1,205
Folate and DNA Methylation: A Review of Molecular Mechanisms and the Evidence for Folate's Role
Crider, K. S., Yang, T. P., Berry, R. J., & Bailey, L. B. (2012) · Advances in Nutrition · doi:10.3945/an.111.000992 · Cited by 1,015
Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy
Lu, Y., Chan, Y.-T., Tan, H.-Y., Li, S., Wang, N., & Feng, Y. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01197-3 · Cited by 499
Identification of direct targets and modified bases of RNA cytosine methyltransferases
Khoddami, V., & Cairns, B. R. (2013) · Nature Biotechnology · doi:10.1038/nbt.2566 · Cited by 483
Chromatin proteins and modifications as drug targets
Helin, K., & Dhanak, D. (2013) · Nature · doi:10.1038/nature12751 · Cited by 427
Metadata
- Authors
- Yang, X., Lay, F., Han, H., & Jones, P. A.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2010-11
- Volume
- 31
- Issue
- 11
- Pages
- 536-546
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W2013250198
- Cited by
- 326
- References
- 134
- FWCI
- 1.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.